Elvitam Syrup

Elvitam Syrup treats epilepsy, a central nervous system disorder, by controlling different kinds of seizures (fits) such as partial onset seizures, tonic-clonic seizures and myoclonic seizures. This medication contains levetiracetam, an anticonvulsant that works by lowering the abnormal excitement in the brain. It is used as a stand-alone treatment or with other medicines to manage seizures. However, while it can control epileptic episodes, it can not wholly cure epilepsy.

Elvitam Syrup should be taken as prescribed by your doctor. It is recommended to take this medication at the same time each day, either on an empty stomach or with your meals. It is typically prescribed as a long-term treatment. It is essential to follow your doctor's instructions and continue taking it as long as directed, even if your symptoms improve. Stopping or missing doses of this medication could worsen your seizures, so it is vital to maintain consistent, regular dosing.

The common side effects of Elvitam Syrup include drowsiness, lack of energy, dizziness, unsteady walking, excessive sleepiness, vomiting, diarrhoea, constipation, double vision and mood swings. These adverse effects usually go away on their own and should not be of concern. If they persist or become worse, contact your doctor.

Elvitam Syrup may be contraindicated (unsafe) for people who have/had kidney problems, depression, suicidal thoughts, mood problems, anaemia and hypersensitivity to levetiracetam. Always let your doctor know of any health conditions you might have. Generally, this medicine is considered safe for most people.

Elvitam Syrup is used in the treatment of epilepsy, a neurological disorder that manifests in the central nervous system. It treats the condition by controlling different kinds of different seizures (fits), precisely three distinct varieties:

Elvitam Syrup contains levetiracetam, an anticonvulsant antiepileptic drug which controls seizures in epileptic patients by lowering the abnormal excitement in the brain.

Levetiracetam is thought to exert its therapeutic effects through its selective binding to specific sites, namely the SV2A proteins, located on the surfaces of nerve cells. This binding event results in the modulation of neuronal activity and the attenuation of electrical signals characteristic of seizure events. In addition, Levetiracetam exhibits inhibitory effects on calcium channels, further contributing to its anticonvulsant properties. Notably, it may also interact with synaptic proteins involved in regulating neurotransmitter release, ultimately leading to the reduction of excitatory activity in the brain.

The exact means through which levetiracetam exerts its antiepileptic properties (its mechanism of action) remain unknown to medical researchers at this point.

• Levetiracetam (medlineplus.gov)
• Levetiracetam (ncbi.nlm.nih.gov)
• KEPPRA (levetiracetam) (accessdata.fda.gov)